Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 31
Filter
Add more filters










Publication year range
1.
Clin Microbiol Infect ; 23(9): 677.e1-677.e3, 2017 Sep.
Article in English | MEDLINE | ID: mdl-28336383

ABSTRACT

OBJECTIVES: To determine if emm pattern-inferred tissue tropisms of Group A streptococcus strains is reflected in their ability to adhere to immortalized human HaCat (keratinocyte) and Detroit 562 (pharyngeal) cell lines. METHODS: Human epithelial cell line monolayers were inoculated with Group A streptococcus, and the percentage of adhered bacteria after a 1-h incubation period was calculated. RESULTS: Of the 21/69 inferred-skin-tropic, and the 25/69 inferred-throat-tropic isolates no preferential adherence was observed to a particular cell line. The 23/69 strains classified as 'generalists', however, showed an overall greater ability to adhere to both cell lines. CONCLUSIONS: Predicted tissue-tropism based on emm patterns is not reflected by preferential adherence to a specific cell line, suggesting that early adhesion events may not be as important in establishing infection at a particular ecological niche than originally expected.


Subject(s)
Bacterial Adhesion/physiology , Streptococcus pyogenes/physiology , Streptococcus pyogenes/pathogenicity , Viral Tropism/physiology , Antigens, Bacterial , Bacterial Outer Membrane Proteins , Carrier Proteins , Cell Line , Epithelial Cells/cytology , Epithelial Cells/microbiology , Humans , Pharynx/cytology , Skin/cytology
2.
J Hum Hypertens ; 27(5): 294-7, 2013 May.
Article in English | MEDLINE | ID: mdl-23151749

ABSTRACT

Genome-wide association study (GWAS) has identified serine/threonine kinase 39 (STK39) as a candidate gene for hypertension. A replication study provided supporting evidence that STK39 functional polymorphism rs35929607 was associated with hypertension. Recently, another study also showed rs6749447 within the STK39 was associated with blood pressure responses. However, these studies were all conducted in Caucasians. Thus, we carried out a case-control study to test whether STK39 is a common candidate gene for hypertension, and to examine the interaction of genetic factors and non-genetic risk factors in the Chinese population. Thousand twenty four hypertensive cases and 1024 controls were genotyped for five polymorphisms. Four single-nucleotide polymorphisms (SNPs) are located within STK39, and rs4977950, the SNP that showed the strongest signal is located in a gene desert. Results indicated that none of these SNPs was associated with hypertension in the Chinese population. Logistic regression analysis found body mass index (BMI) and triglyceride level were higher in the hypertension group when compared with the control group. Multifactor dimensionality reduction analysis indicated that the interaction between BMI and rs4977950 may have an impact on hypertension. Taken together, the present study found no evidence that STK39 was associated with hypertension in the Chinese population. Instead, non-genetic risk factors such as BMI have an important role in Chinese hypertensive subjects, and the 'missing inheritability' requires further investigation.


Subject(s)
Asian People/genetics , Hypertension/genetics , Polymorphism, Single Nucleotide , Protein Serine-Threonine Kinases/genetics , Adult , Aged , Body Mass Index , Case-Control Studies , Female , Genome-Wide Association Study , Humans , Male , Middle Aged , Triglycerides/blood
3.
Hum Exp Toxicol ; 31(12): 1251-61, 2012 Dec.
Article in English | MEDLINE | ID: mdl-22653687

ABSTRACT

The effect of the natural compound phenethyl isothiocyanate (PEITC) on cytosolic Ca(2+) concentrations ([Ca(2+)](i)) and viability in MDCK renal cells is unknown. This study explored whether PEITC changed [Ca(2+)](i) in MDCK cells using the Ca(2+)-sensitive fluorescent dye fura-2. PEITC at 200-700 µM increased [Ca(2+)](i) in a concentration-dependent manner. The signal was reduced by removing extracellular Ca(2+). PEITC-induced Ca(2+) influx was inhibited by nifedipine, econazole, SK&F 96365 and protein kinase C modulators. In Ca(2+)-free medium, treatment with the endoplasmic reticulum Ca(2+) pump inhibitor thapsigargin (TG) or 2,5-di-tert-butylhydroquinone (BHQ) inhibited PEITC-induced rise in [Ca(2+)](i). Incubation with PEITC also inhibited TG or BHQ-induced rise in [Ca(2+)](i). Inhibition of phospholipase C with U73122 abolished PEITC-induced rise in [Ca(2+)](i). At 15-75 µM, PEITC decreased viability. The cytotoxic effect of PEITC was enhanced by chelating cytosolic Ca(2+) with 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid/acetoxymethyl ester. Annexin V-FITC data suggest that 20 and 50 µM PEITC induced apoptosis. At 10 and 15 µM, PEITC did not increase reactive oxygen species (ROS) production. Together, in renal tubular cells, PEITC-induced rise in [Ca(2+)](i) by inducing phospholipase C-dependent Ca(2+) release from endoplasmic reticulum and Ca(2+) entry via store-operated Ca(2+) channels. PEITC induced apoptosis in a concentration-dependent, ROS/Ca(2+)-independent manner.


Subject(s)
Calcium Signaling/drug effects , Calcium/metabolism , Enzyme Inhibitors/toxicity , Isothiocyanates/toxicity , Kidney Tubules/drug effects , Animals , Apoptosis/drug effects , Calcium Signaling/physiology , Cell Survival/drug effects , Cytosol/drug effects , Cytosol/metabolism , Dogs , Econazole/pharmacology , Egtazic Acid/analogs & derivatives , Egtazic Acid/pharmacology , Imidazoles/pharmacology , Kidney Tubules/metabolism , Kidney Tubules/pathology , Madin Darby Canine Kidney Cells , Nifedipine/pharmacology , Thapsigargin/pharmacology
4.
Int J Obes (Lond) ; 34(11): 1589-98, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20351731

ABSTRACT

BACKGROUND: Excess caloric intake is strongly associated with the development of increased adiposity, glucose intolerance, insulin resistance, dyslipidemia, and hyperleptinemia (that is the cardiometabolic syndrome). Research efforts have focused attention primarily on the quality (that is nutritional content) and/or quantity of ingested calories as potential causes for diet-induced pathology. Despite growing acceptance that biological rhythms profoundly influence energy homeostasis, little is known regarding how the timing of nutrient ingestion influences development of common metabolic diseases. OBJECTIVE: To test the hypothesis that the time of day at which dietary fat is consumed significantly influences multiple cardiometabolic syndrome parameters. RESULTS: We report that mice fed either low- or high-fat diets in a contiguous manner during the 12 h awake/active period adjust both food intake and energy expenditure appropriately, such that metabolic parameters are maintained within a normal physiologic range. In contrast, fluctuation in dietary composition during the active period (as occurs in human beings) markedly influences whole body metabolic homeostasis. Mice fed a high-fat meal at the beginning of the active period retain metabolic flexibility in response to dietary challenges later in the active period (as revealed by indirect calorimetry). Conversely, consumption of high-fat meal at the end of the active phase leads to increased weight gain, adiposity, glucose intolerance, hyperinsulinemia, hypertriglyceridemia, and hyperleptinemia (that is cardiometabolic syndrome) in mice. The latter perturbations in energy/metabolic homeostasis are independent of daily total or fat-derived calories. CONCLUSIONS: The time of day at which carbohydrate versus fat is consumed markedly influences multiple cardiometabolic syndrome parameters.


Subject(s)
Dietary Carbohydrates/administration & dosage , Dietary Fats/administration & dosage , Dyslipidemias/physiopathology , Insulin Resistance/physiology , Obesity/physiopathology , Weight Gain/physiology , Animals , Diet , Energy Intake/physiology , Male , Mice , Periodicity , Time Factors
5.
Neuroscience ; 167(1): 185-98, 2010 Apr 28.
Article in English | MEDLINE | ID: mdl-20149848

ABSTRACT

Progressive changes in the muscle tone and stretch reflex after spinal cord injury (SCI) provide insight into the time-course development of spasticity. This study quantified the time-course changes of hypertonia for rats following SCI of T8 hemisection. A miniature manual stretching device measured the reactive torque via a pair of pressure sensing balloons; the angular displacement was measured via an optoelectronic device. Various stretching frequencies were tested, specifically 1/3, 1/2, 1, 3/2 and 2 Hz. The reactive torque and angular displacement were used to derive the viscous and elastic components representing the viscosity and stiffness of the rat's ankle joint. The enhanced velocity-dependent properties of spasticity were observed in the SCI hemisection rats (n=9) but not in the controls (n=9). Time-course measurements from pre-surgery to 56 days following SCI showed that the muscle tone of the hemisection rats dropped immediately after spinal shock and then gradually increased to reach a peak around 21 days postinjury (P<0.01). The muscle tone remained at least 75% of the peak value up to the end of an 8 week observation period (P<0.05). The changes of muscle tone can also be verified from the electrophysiological evaluations of electromyography (EMG) (P<0.05). In addition to conventional BBB motor behavior score, our results provided time-course quantification of the biomechanical and electrophysiological properties of muscle tone from the onset of SCI. Such data are useful for investigating progressive recovery of spinal damage in animal model and for future objective assessment of improved treatment for SCI human subjects.


Subject(s)
Muscle Hypertonia/physiopathology , Muscle Spasticity/physiopathology , Spinal Cord Injuries/physiopathology , Animals , Ankle Joint/physiopathology , Biomechanical Phenomena , Disability Evaluation , Functional Laterality , Locomotion/physiology , Male , Muscle Tonus/physiology , Rats , Rats, Wistar , Reflex, Stretch/physiology , Time Factors
6.
Hum Exp Toxicol ; 28(5): 301-8, 2009 May.
Article in English | MEDLINE | ID: mdl-19661262

ABSTRACT

The effect of thimerosal on cytosolic free Ca(2+) concentrations ([Ca(2+)](i) ) in human oral cancer cells (OC2) is unclear. This study explored whether thimerosal changed basal [Ca(2+)](i) levels in suspended OC2 cells using fura-2. Thimerosal at concentrations between 1and 50 microM increased [Ca(2+)](i) in a concentration-dependent manner. The Ca(2+) signal was reduced partly by removing extracellular Ca( 2+). Thimerosal-induced Ca(2+) influx was not blocked by L-type Ca(2+) entry inhibitors and protein kinase C modulators (phorbol 12-myristate 13-acetate [PMA] and GF109203X). In Ca(2+)-free medium, 50 microM thimerosal failed to induce a [Ca(2+)](i) rise after pretreatment with thapsigargin (an endoplasmic reticulum Ca(2+) pump inhibitor). Inhibition of phospholipase C with U73122 did not change thimerosal-induced [Ca(2+)](i) rises. At concentrations between 5 and 10 microM, thimerosal killed cells in a concentration-dependent manner. The cytotoxic effect of 8 muM thimerosal was potentiated by prechelating cytosolic Ca(2+) with the Ca(2+) chelator 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetate/acetomethyl (BAPTA/ AM). Flow cytometry data suggested that 1-7 microM thimerosal-induced apoptosis in a concentration-dependent manner. Collectively, in OC2 cells, thimerosal-induced [Ca(2+)](i) rises by causing phospholipase C-independent Ca(2+) release from the endoplasmic reticulum and Ca(2+) influx through non-L-type Ca(2+) channels. Thimerosal killed cells in a concentration-dependent manner through apoptosis.


Subject(s)
Calcium/metabolism , Cell Survival/drug effects , Mouth Neoplasms/pathology , Thimerosal/toxicity , Apoptosis/drug effects , Calcium Channel Blockers/pharmacology , Calcium Channels, L-Type/drug effects , Cell Line, Tumor , Chelating Agents/pharmacology , Dose-Response Relationship, Drug , Egtazic Acid/analogs & derivatives , Egtazic Acid/pharmacology , Endoplasmic Reticulum/drug effects , Endoplasmic Reticulum/pathology , Enzyme Inhibitors/pharmacology , Estrenes/pharmacology , Humans , Phosphodiesterase Inhibitors/pharmacology , Protein Kinase C/antagonists & inhibitors , Pyrrolidinones/pharmacology , Thapsigargin/pharmacology , Type C Phospholipases/antagonists & inhibitors , Type C Phospholipases/metabolism
7.
Opt Express ; 16(2): 920-6, 2008 Jan 21.
Article in English | MEDLINE | ID: mdl-18542166

ABSTRACT

Optically modulated internal strain has been observed in InGaN quantum dots (QDs) deposited on SiN(x) nano masks. The modulated internal strain can induce a number of intriguing effects, including the change of refractive index and the redshift of InGaN A(1)(LO) phonon. The underlying mechanism can be well accounted for in terms of the variation of internal strain through the converse piezoelectric effect arising from the screening of the internal electric field due to spatial separation of photoexcited electrons and holes. Our results point out a convenient way for the fine tuning of physical properties in nitride-based semiconductor nanostructures, which is very important for high quality optoelectronic devices.


Subject(s)
Crystallization/methods , Gallium/chemistry , Indium/chemistry , Nanotechnology/instrumentation , Nanotechnology/methods , Quantum Dots , Silicon Compounds/chemistry , Transducers , Elasticity , Equipment Design , Equipment Failure Analysis , Materials Testing , Stress, Mechanical , Surface Properties
8.
Prikl Biokhim Mikrobiol ; 43(4): 495-500, 2007.
Article in English | MEDLINE | ID: mdl-17929580

ABSTRACT

This study aimed to evaluate the antioxidant activities of a cultured medicinal fungus--Armillariella mellea (Vahl. ex Fr.) Karst. (AM). Three antioxidant assay systems, namely cytochrome c, xanthine oxidase inhibition and FeCl2-ascorbic acid stimulated lipid peroxidation in rat tissue homogenate tests, were used. Total flavonoid and phenol contents of AM extracts were also analyzed. Results showed that both aqueous (AM-H2O) and ethanolic (AM-EtOH) extracts of solid state cultured AM showed antioxidant activities in a concentration-dependent manner. At concentrations 1-100 microg/ml, the free radical scavenging activity was 73.7-92.1% for AM-H2O, and 60.0-90.8% for AM-EtOH. These extracts also showed an inhibitory effect on xanthine oxidase activity, but with a lesser potency (IC50 - 9.17 microg/ml for AM-H2O and 7.48 microg/ml for AM-EtOH). In general, AM-H2O showed a stronger anti-lipid peroxidation activity on different rat's tissues than AM-EtOH. However, both AM extracts displayed a weak inhibitory effect on lipid peroxidation in plasma. Interestingly, the anti-lipid peroxidation activity of AM-H2O (IC50 - 6.66 microg/ml) in brain homogenate was as good as alpha-tocopherol (IC50 - 5.42 microg/ml). AM-H2O (80.0 mg/g) possessed a significant higher concentration of total flavonoids than AM-EtOH (30.0 mg/g), whereas no difference was noted in the total phenol content between these two extracts. These results conclude that AM extracts possess potent free radical scavenging and anti-lipid peroxidation activities, especially the AM-H20 in the brain homogenate.


Subject(s)
Agaricales/metabolism , Antioxidants/metabolism , Flavonoids/metabolism , Phenol/metabolism , Animals , Brain/metabolism , Cytochromes c/metabolism , Free Radical Scavengers/metabolism , In Vitro Techniques , Lipid Peroxidation , Liver/metabolism , Rats , Tissue Extracts , Xanthine Oxidase/antagonists & inhibitors , Xanthine Oxidase/metabolism
9.
J Ethnopharmacol ; 108(3): 407-13, 2006 Dec 06.
Article in English | MEDLINE | ID: mdl-16820275

ABSTRACT

Physalis peruviana L. (PP) is a medicinal herb widely used in folk medicine. In this study, supercritical carbon dioxide (SFE-CO2) method was employed to obtain three different PP extracts, namely SCEPP-0, SCEPP-4 and SCEPP-5. The total flavonoid and phenol concentrations, as well as antioxidant and anti-inflammatory activities of these extracts were analyzed and compared with aqueous and ethanolic PP extracts. Among all the extracts tested, SCEPP-5 demonstrated the highest total flavonoid (234.63+/-9.61 mg/g) and phenol (90.80+/-2.21 mg/g) contents. At concentrations 0.1-30 microg/ml, SCEPP-5 also demonstrated the strongest superoxide anion scavenging activity and xanthine oxidase inhibitory effect. At 30 microg/ml, SCEPP-5 significantly prevented lipopolysaccharide (LPS; 1 microg/ml)-induced cell cytotoxicity in murine macrophage (Raw 264.7) cells. At 10-50 microg/ml, it also significantly inhibited LPS-induced NO release and PGE2 formation in a dose-dependent pattern. SCEPP-5 at 30 microg/ml remarkably blocked the LPS induction of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) expression. Taken together, these results suggest that SCEPP-5, an extract of SFE-CO2, displayed the strongest antioxidant and anti-inflammatory activities as compared to other extracts. Its protection against LPS-induced inflammation could be through the inhibition of iNOS and COX-2 expression.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Antioxidants/pharmacology , Carbon Dioxide/chemistry , Physalis/chemistry , Plant Extracts/pharmacology , Animals , Anti-Inflammatory Agents/chemistry , Anti-Inflammatory Agents/isolation & purification , Antioxidants/chemistry , Antioxidants/isolation & purification , Blotting, Western , Cell Line , Cell Survival/drug effects , Cyclooxygenase 2/metabolism , Dinoprostone/metabolism , Dose-Response Relationship, Drug , Enzyme Activation/drug effects , Flavonoids/metabolism , Free Radical Scavengers/metabolism , Lipopolysaccharides/pharmacology , Macrophages/cytology , Macrophages/drug effects , Macrophages/metabolism , Nitric Oxide/metabolism , Nitric Oxide Synthase Type II/metabolism , Phenol/metabolism , Plant Extracts/chemistry , Plant Extracts/isolation & purification , Xanthine Oxidase/metabolism
10.
Int J Impot Res ; 18(2): 146-9, 2006.
Article in English | MEDLINE | ID: mdl-16094412

ABSTRACT

To assess the compliance of treatment, its affecting factors, and reasons for dropout, a questionnaire was mailed to a cohort of 2139 subjects who received sildenafil prescriptions for erectile dysfunction (ED) at our institution from 1999 to 2002. A total of 726 subjects (34%) with a mean age of 67 years answered the questionnaires. The response rate for sildenafil treatment was 67%. Of these sildenafil responders, 43% reported that they continued using sildenafil while 57% did not, in a mean follow-up of 3 years. Common reasons for discontinuation were effect below expectations, high cost, loss of interest in sex, and inconvenience in obtaining sildenafil. The continuers showed a higher rate than the discontinuers (P < 0.05) of having tried other treatments, dose titration, and a dose higher than 50 mg. The discontinuers reported having a lower mean responding dose and improvement score post sildenafil treatment than the continuers. In conclusion, effect below expectations was the leading reason for discontinuation of sildenafil treatment. How ED subjects tried the medication and the adequacy of education in the initial treatment period may impact the compliance of sildenafil treatment.


Subject(s)
Erectile Dysfunction/drug therapy , Patient Compliance/statistics & numerical data , Piperazines/therapeutic use , Aged , Drug Costs , Humans , Male , Middle Aged , Patient Dropouts/psychology , Patient Education as Topic , Patient Satisfaction , Piperazines/adverse effects , Piperazines/economics , Purines , Sildenafil Citrate , Sulfones , Surveys and Questionnaires
11.
Acta Crystallogr D Biol Crystallogr ; 60(Pt 11): 2067-9, 2004 Nov.
Article in English | MEDLINE | ID: mdl-15502329

ABSTRACT

Polyamines, such as putrescine, spermidine and spermine, are essential for the regulation of cell proliferation and differentiation in most organisms. Spermidine synthase catalyzes the transfer of the aminopropyl group from decarboxylated S-adenosylmethionine to putrescine in the biosynthesis of spermidine. In this study, spermidine synthase of Helicobacter pylori has been overexpressed in Escherichia coli and purified. Two kinds of spermidine synthase crystals were obtained. One belongs to the monoclinic P2(1) space group, with unit-cell parameters a = 62.78, b = 58.24, c = 74.28 A, beta = 90.9 degrees , and the other belongs to the orthorhombic C222(1) space group, with unit-cell parameters a = 100.43, b = 128.55, c = 143.60 A.


Subject(s)
Helicobacter pylori/enzymology , Spermidine Synthase/chemistry , Crystallization , Crystallography, X-Ray
12.
Int J Impot Res ; 15(6): 412-7, 2003 Dec.
Article in English | MEDLINE | ID: mdl-14671659

ABSTRACT

We retrospectively assessed the clinical uses and results of sildenafil in the treatment of erectile dysfunction (ED) in daily clinical practice from a cohort of 1658 subjects at a multispecialty medical center from 1999 to 2001 through a chart review, mailed questionnaire and telephone interview. The overall follow-up rate was 77.8% (1290/1658). The mean age was 63.8 y and ED duration was 3.4 y, and 44.6% of them had one or more concomitant conditions. The mean score of the International Index of Erectile Function erectile function domain was 12.7 in 314 nonselective subjects, and 75% of them had moderate to severe ED. The average number of purchase-visits and tablets of sildenafil purchased was 2.27 and 10.8 per person, respectively, and the prescription refill rate was 58.6%. Urology accounts for 91.4% of the specialties of prescribers. The response rate was 72.0%, which was significantly lower in subjects with diabetes, ischemic heart disease and following radical pelvic surgery than those without. Subjects with psychogenic etiology had the highest response rate, while those following radical pelvic surgery the lowest. Of the nonresponders, 67% did not try the maximum dose of 100 mg and 71.1% bought no more than four tablets. Adverse events were reported in 20.1% of the subjects. No one discontinued the treatment because of the adverse events. Mortality occurred in 17 subjects and none was considered related to sildenafil use. In conclusion, sildenafil was effective and safe in the treatment of ED in clinical practice. Compared with clinical trials or prospective clinical practice based studies, lack of dose titration, less follow-up visits and inadequate attempts before giving up were the main shortfalls in daily practice.


Subject(s)
Erectile Dysfunction/drug therapy , Piperazines/adverse effects , Piperazines/supply & distribution , Vasodilator Agents/adverse effects , Vasodilator Agents/supply & distribution , Adult , Aged , Aged, 80 and over , Cause of Death , Comorbidity , Drug Prescriptions/statistics & numerical data , Erectile Dysfunction/mortality , Follow-Up Studies , Humans , Incidence , Male , Middle Aged , Piperazines/administration & dosage , Purines , Retrospective Studies , Sildenafil Citrate , Sulfones , Vasodilator Agents/administration & dosage
13.
J Pept Res ; 60(3): 143-9, 2002 Sep.
Article in English | MEDLINE | ID: mdl-12213123

ABSTRACT

One of the critical intracellular signal transduction pathways involves the binding of the Grb2 SH2 domain to the phosphotyrosine (pTyr) motifs on growth factor receptors, such as epidermal growth factor receptor (EGFR) and erbB2, leading to downstream activation of the oncogenic Ras signaling pathway. Therefore, the Grb2 SH2 domain has been chosen as our target for the development of potential anticancer agents. As a continuation of our earlier work, herein we report the design and synthesis of new peptide analogs, and their inhibitory effect on the Grb2 SH2 domain using surface plasmon resonance (SPR) technology. These novel agents do not contain phosphotyrosine or phosphotyrosine mimics. Binding interactions between these peptides and the Grb2 SH2 domain were measured and analyzed using a BIAcore X instrument, which provides detailed information on the real-time detection of the binding interaction. The results of this study should provide important information for the further development of peptides or peptidomimetics with high affinity for the Grb2 SH2 domain.


Subject(s)
Adaptor Proteins, Signal Transducing , Enzyme Inhibitors/chemistry , Peptides/chemistry , Proteins/antagonists & inhibitors , src Homology Domains , Biotin/chemistry , Chromatography, High Pressure Liquid/methods , Dose-Response Relationship, Drug , Electrophoresis, Polyacrylamide Gel , Enzyme Inhibitors/metabolism , GRB2 Adaptor Protein , Inhibitory Concentration 50 , Kinetics , Peptides/metabolism , Protein Binding , Proteins/metabolism , Spectrometry, Mass, Fast Atom Bombardment , Surface Plasmon Resonance
14.
J Diabetes Complications ; 16(5): 363-70, 2002.
Article in English | MEDLINE | ID: mdl-12200082

ABSTRACT

Galactose-fed dogs develop retinal capillary changes similar to diabetic retinopathy with pericyte degeneration as the initial lesion. This is followed by the formation of microaneurysms, hemorrhages, and some areas of acellularity. To investigate the mechanisms for selective pericyte degeneration, retinal capillary pericytes and endothelial cells isolated from beagle dog retina were cultured for 2 weeks in Dulbecco's modified Eagle's medium (DMEM) containing 50 mM D-galactose. Apoptosis was detected in pericytes but not endothelial cells by in situ terminal deoxynucleotidyl transferase (TdT)-mediated biotin-dUTP nick end labelling (TUNEL) staining and the DNA fragmentation assay on agarose gel electrophoresis. This apoptosis was prevented by the addition of the aldose reductase inhibitor AL 1576 to the culture medium containing galactose. Apoptosis was not observed when pericytes were similarly cultured in control DMEM medium. These data support the premise that the selective degeneration of retinal capillary pericytes observed in galactose-fed dogs is linked to increased aldose reductase activity in these cells.


Subject(s)
Aldehyde Reductase/genetics , Apoptosis/drug effects , Capillaries/pathology , Galactitol/metabolism , Galactose/toxicity , Pericytes/pathology , Retinal Vessels/drug effects , Animals , Capillaries/drug effects , Cells, Cultured , Dogs , Gene Expression Regulation, Enzymologic/drug effects , Male , Pericytes/drug effects , Pericytes/metabolism , Retinal Vessels/pathology
16.
Zhonghua Yi Xue Za Zhi (Taipei) ; 64(5): 292-8, 2001 May.
Article in English | MEDLINE | ID: mdl-11499339

ABSTRACT

BACKGROUND: In order to extend the feasibility of hyperbaric oxygen therapy in the urological field, the present study aimed to investigate the dissolution activity of human infective stones in UROCITRA solution under hyperbaric oxygen condition. METHODS: The dissolution activity of 7 struvite and 11 mixed struvite and carbonate apatite stones in UROCITRA solution were studied under 2.5 atmosphere (atm) hyperbaric oxygen (HBO) status in a Sigma I N-124 monoplace chamber. Another 7 struvite and 10 mixed struvite and carbonate apatite stones were also studied under normal condition. Chemolysis was performed in a drip device with a 150-ml/hour continuous flow rate. RESULTS: Under 2.5 atm HBO status, the PO2 of UROCITRA solution was 365 +/- 44 mmHg, which was significantly higher than that of tap water (113 +/- 62 mmHg) and UROCITRA solution (125 +/- 12 mmHg) under normobaric condition (p < 0.001). The decreases in the stone weight of struvite under normobaric condition were 31 +/- 8.8% after 2 h and 48 +/- 15% after 4 h of treatment. The HBO-enriched UROCITRA solution did not increase the dissolution activity as reflected by comparable decreases in the dried stone weight (31.2 +/- 14.6% and 54 +/- 19% at the 2nd and 4th post-treatment hours, respectively, p > 0.05). Similarly, there was no significant difference in the percent stone weight decrease of the mixed struvite and carbonate apatite stones under either HBO or normobaric condition. The dissolution responsiveness of struvite was significantly greater than that of the mixed struvite and carbonate apatite stones. CONCLUSIONS: The chemolysis of struvite in UROCITRA solution is significantly greater than that of the mixed struvite and carbonate apatite stones. However, the UROCITRA solution enriched with HBO does not enhance the dissolution of infective stones.


Subject(s)
Calculi/therapy , Hyperbaric Oxygenation , Pyelonephritis/therapy , Humans , Solubility
17.
Cancer ; 91(11): 2065-70, 2001 Jun 01.
Article in English | MEDLINE | ID: mdl-11391586

ABSTRACT

BACKGROUND: Epithelial ovarian neoplasms are rare in patients under the age of 21 years. This is a report of a series of such patients documenting their presentation, histologic type, stage of disease, treatment, and outcome. METHODS: Clinical findings, histology, stage, treatment, and outcomes of 19 patients with epithelial ovarian neoplasia are reported. All histology was rereviewed. RESULTS: The median age at the time of diagnosis was 19.7 years (range, 14.1-21.8 years), and the median follow-up was 5.6 years (range, 0.2-19.5 years). The most common presenting symptom was dysmenorrhea (100%) followed by abdominal pain (68%), and the initial diagnosis usually was made ultrasonographically. There were nine (47%) serous tumors, 7 (37%) mucinous tumors, 2 (11%) small cell carcinomas, and 1 (5%) endometrioid carcinoma. Seventy-nine percent of tumors were unilateral, and 84% were low malignant potential or well differentiated tumors. Surgical treatment included unilateral salpingo-oophorectomy in 12 patients (63%), total abdominal hysterectomy and bilateral salpingo-oophorectomy in 6 patients (32%), and ovarian cystectomy in 1 patient (5%). Fifteen patients (79%) had Stage I disease, and 4 patients (21%) had Stage III disease at the time of diagnosis. There were two deaths in this series, and both occurred in patients with small cell anaplastic carcinoma. CONCLUSIONS: Epithelial ovarian neoplasias are rare in patients in this age group but must be included in the differential diagnosis of an ovarian mass. Most patients present with Stage I tumors of low malignant potential. In these patients, good survival is achieved with unilateral salpingo-oophorectomy and preservation of fertility. In contrast, small cell carcinomas are very aggressive, and patients with this variant require intensive therapy.


Subject(s)
Neoplasms, Glandular and Epithelial/pathology , Ovarian Neoplasms/pathology , Abdominal Pain/etiology , Adolescent , Adult , Age of Onset , Diagnosis, Differential , Dysmenorrhea/etiology , Fallopian Tubes/surgery , Female , Humans , Neoplasm Staging , Neoplasms, Glandular and Epithelial/surgery , Ovarian Neoplasms/surgery , Ovariectomy , Prognosis , Retrospective Studies , Treatment Outcome
18.
Nat Cell Biol ; 2(7): 428-34, 2000 Jul.
Article in English | MEDLINE | ID: mdl-10878808

ABSTRACT

The beta-amyloid precursor protein (beta-APP), which is involved in the pathogenesis of Alzheimer's disease, and the Notch receptor, which is responsible for critical signalling events during development, both undergo unusual proteolysis within their transmembrane domains by unknown gamma-secretases. Here we show that an affinity reagent designed to interact with the active site of gamma-secretase binds directly and specifically to heterodimeric forms of presenilins, polytopic proteins that are mutated in hereditary Alzheimer's and are known mediators of gamma-secretase cleavage of both beta-APP and Notch. These results provide evidence that heterodimeric presenilins contain the active site of gamma-secretase, and validate presenilins as principal targets for the design of drugs to treat and prevent Alzheimer's disease.


Subject(s)
Endopeptidases/metabolism , Membrane Proteins/metabolism , Protease Inhibitors/chemistry , Protease Inhibitors/metabolism , Affinity Labels , Alzheimer Disease/drug therapy , Alzheimer Disease/enzymology , Amyloid Precursor Protein Secretases , Amyloid beta-Peptides/metabolism , Amyloid beta-Protein Precursor/genetics , Amyloid beta-Protein Precursor/metabolism , Animals , Aspartic Acid Endopeptidases , CHO Cells , Cricetinae , Dimerization , Humans , Membrane Proteins/chemistry , Microsomes/chemistry , Microsomes/metabolism , Molecular Weight , Peptide Fragments/chemistry , Peptide Fragments/metabolism , Presenilin-1 , Presenilin-2 , Protease Inhibitors/pharmacology , Protease Inhibitors/therapeutic use , Protein Binding , Protein Processing, Post-Translational , Transfection
19.
J Diabetes Complications ; 13(3): 151-8, 1999.
Article in English | MEDLINE | ID: mdl-10509875

ABSTRACT

Dogs fed a diet containing 30% galactose develop diabetes-like retinal capillary changes. As retinal capillary occlusion is commonly observed in diabetic retinopathy, neutrophil apoptosis and the interaction of neutrophils with retinal capillary endothelial cells were investigated. Neutrophils were isolated with Ficoll-Hypaque centrifugation from dogs fed a 30% galactose diet and dogs fed a normal, control diet containing 30% non-nutrient filler. Apoptosis of neutrophils was microscopically examined after incubation at 37 degrees C for 3 hours with either 100 U/mL tumor necrosis factor alpha (TNF-alpha), 2 microg/mL cycloheximide or 50 ng/mL phorbol 12-myristate 13-acetate (PMA). Neutrophil adhesion to dog retinal capillary endothelial cells was examined by counting the cells attached to the surface of endothelial cells after the incubation in the presence of either 100 U/mL TNF-alpha or 5 microg/mL lipopolysaccharides (LPS) at 37 degrees C for 3 hours. With all three stimulants TNF-alpha, cycloheximide and PMA, the rate of apoptosis was significantly lower for neutrophils isolated from galactose-fed dogs compared to control dogs fed a normal diet. Preincubation of neutrophils from control dogs in medium containing 30% galactose for 3 hours did not affect the rate of apoptosis. Neutrophil adhesion to retinal capillary endothelial cells induced by incubation in the presence of either 100 U/mL TNF-alpha or 5 microg/ml LPS was significantly higher with neutrophils isolated from galactose-fed dogs than those from control dogs. The data indicate that long-term galactose feeding is essential with development of various neutrophil dysfunctions. These neutrophil changes may contribute to the development of retinal microangiopathy associated with diabetes and galactosemia.


Subject(s)
Apoptosis , Cell Adhesion , Diabetes Mellitus, Experimental/pathology , Endothelium, Vascular/pathology , Neutrophils/pathology , Retinal Vessels/pathology , Animals , Capillaries/pathology , Cycloheximide/pharmacology , DNA Fragmentation , Diabetes Mellitus, Experimental/chemically induced , Dogs , Enzyme Activation/drug effects , Galactose , Male , Protein Kinase C/metabolism , Protein Synthesis Inhibitors/pharmacology , Tetradecanoylphorbol Acetate/pharmacology , Tumor Necrosis Factor-alpha/pharmacology
20.
Biochem Pharmacol ; 58(3): 517-24, 1999 Aug 01.
Article in English | MEDLINE | ID: mdl-10424772

ABSTRACT

The sympathoneural neurotransmitter norepinephrine (NE) is deaminated to 3,4-dihydroxymandelaldehyde (DHMAL) and subsequently converted to either 3,4-dihydroxymandelic acid (DHMA) or 3,4-dihydroxyphenylglycol (DHPG). In this study, we investigated the relative importance of aldose reductase versus aldehyde reductase in the formation of DHPG from DHMAL. The in vitro incubation of NE with aldose reductase in the presence of monoamine oxidase (MAO) resulted in the formation of DHPG, which was confirmed by mass spectrometry. Although aldehyde reductase also generated DHPG, its activity was much lower than that of aldose reductase. With northern blotting, the expression of both aldose reductase and aldehyde reductase was detected in rat superior cervical ganglia. However, with western blotting, only aldose reductase was immunologically detectable. Treatment of rats with aldose reductase inhibitors for 3 days increased the plasma level of DHMA. There was no correlation between the selectivity of inhibitors and effects on NE metabolite levels. A significant decrease in DHPG, however, was obtained only with an extremely high dose (9 mg/kg/day) of the nonselective inhibitor AL 1576. The present study confirmed that aldose reductase generates DHPG from NE in the presence of MAO. In rat sympathetic neurons, aldose reductase appears to be more important than aldehyde reductase for the formation of DHPG. However, when aldose reductase is inhibited, it appears that aldehyde reductase can compensate for the conversion of DHMAL to DHPG, indicating redundancy in the reduction pathway.


Subject(s)
Aldehyde Reductase/metabolism , Methoxyhydroxyphenylglycol/analogs & derivatives , Norepinephrine/metabolism , Aldehyde Reductase/antagonists & inhibitors , Animals , Deamination , Enzyme Inhibitors/pharmacology , Fluorenes/pharmacology , Hydantoins/pharmacology , Male , Methoxyhydroxyphenylglycol/metabolism , Rats , Rats, Sprague-Dawley , Sorbitol/metabolism , Superior Cervical Ganglion/enzymology , Superior Cervical Ganglion/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL